Kirti Shila Sonkar

Dr. Kirti Shila Sonkar

Qbiotix Developments Ltd, Sandwich, UK
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2021 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
LPLove Panchariya
Love Panchariya
WKWajahat Ali Khan
Wajahat Ali Khan
SKShobhan Kuila
Shobhan Kuila
Kirti Shila SonkarKirti Shila Sonkar
Kirti Shila Sonkar
SSSibasis Sahoo
Sibasis Sahoo
AAArulandu Arockiasamy
Arulandu Arockiasamy
Zn 2+ binds to the active site of the SARS-CoV-2 main protease (Mpro), and inhibits enzyme activity and viral replication in vitro .

1 April 2015 in Biocatalysis and Agricultural Biotechnology
Verified
Journal Article
Closed access
Kirti Shila SonkarKirti Shila Sonkar
Kirti Shila Sonkar
MPManendra Pachauri
Manendra Pachauri
AKAmit Kumar
Amit Kumar
ASAnkita Shukla
Ankita Shukla
MPMonika Patel
Monika Patel
MJMedicherla V. Jagannadham
Medicherla V. Jagannadham

13 May 2024 in Brain
Verified
Journal Article
Open access
PDF file
Kirti Shila SonkarKirti Shila Sonkar
Kirti Shila Sonkar
DCDanae Campos-Melo
Danae Campos-Melo
VNVeronica Noches
Veronica Noches
CMCrystal McLellan
Crystal McLellan
RSRobert Szabla
Robert Szabla
MSMichael Strong
Michael Strong
Aggregation of the RNA-binding protein TAR DNA binding protein (TDP-43) is a hallmark of TDP-proteinopathies including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). As TDP-43 aggregation and dysregulation are causative of neuronal death, there is a special interest in targeting this protein as a therapeutic approach. Previously, we found that TDP-43 extensively co-aggregated with the dual function protein GEF (guanine exchange factor) and RNA-binding protein rho guanine nucleotide exchange factor (RGNEF) in ALS patients. Here, we show that an N-terminal fragment of RGNEF (NF242) interacts directly with the RNA recognition motifs of TDP-43 competing with RNA and that the IPT/TIG domain of NF242 is essential for this interaction. Genetic expression of NF242 in a fruit fly ALS model overexpressing TDP-43 suppressed the neuropathological phenotype increasing lifespan, abolishing motor defects and preventing neurodegeneration. Intracerebroventricular injections of AAV9/NF242 in a severe TDP-43 murine model (rNLS8) improved lifespan and motor phenotype, and decreased neuroinflammation markers. Our results demonstrate an innovative way to target TDP-43 proteinopathies using a protein fragment with a strong affinity for TDP-43 aggregates and a mechanism that includes competition with RNA sequestration, suggesting a promising therapeutic strategy for TDP-43 proteinopathies such as ALS and FTD.

1 March 2013 in American Journal of Biochemistry and Biotechnology
Verified
Journal Article
Open access
PDF file
RGRavi Kumar Gundampati
Ravi Kumar Gundampati
SSShraddha Sahu
Shraddha Sahu
Kirti Shila SonkarKirti Shila Sonkar
Kirti Shila Sonkar
MDMira Debnath
Mira Debnath
ASAvinash Kumar Srivastava
Avinash Kumar Srivastava
MJMedicherla Venkata Jagannadham
Medicherla Venkata Jagannadham
A.niger Rnase was designed from ACTBIND (PDB ID: 3D3Z). Yeast actin-human gelsolin segment 1 complex (PDB ID: 1YAG) was used as template for L. donovani actin protein for 3D model in Modeller9v8. These models were testified by PROCHECK, ERRAT, WHAT-IF, PROSA2003 and VERIFY-3D. All evidences suggest that the geometric quality of the backbone conformation, energy profile, residue interaction and contact of the structures were well within the limits of reliable structures. The interaction energy of docking was calculated using the HEX server. Etotal and calculated RMSD values were -1.902, -9.323 kcal moL-1 and 0.402 Å, respectively. The study presented here has an advantage to design molecules that may have antileishmanial activity.

19 April 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Kirti Shila SonkarKirti Shila Sonkar
Kirti Shila Sonkar
VAV. Mohan Murali Achary
V. Mohan Murali Achary
SSSibasis Sahoo
Sibasis Sahoo
MRMalireddy K. Reddy
Malireddy K. Reddy
AAArulandu Arockiasamy
Arulandu Arockiasamy

15 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
LPLove Panchariya
Love Panchariya
WKWajahat Ali Khan
Wajahat Ali Khan
SKShobhan Kuila
Shobhan Kuila
Kirti Shila SonkarKirti Shila Sonkar
Kirti Shila Sonkar
SSSibasis Sahoo
Sibasis Sahoo
AAArulandu Arockiasamy
Arulandu Arockiasamy
Zinc deficiency is linked to poor prognosis in COVID-19 patients while clinical trials with Zinc demonstrate better clinical outcome. The molecular target and mechanistic details of anti-coronaviral activity of Zinc remain obscure. We show that ionic Zinc not only inhibits SARS-CoV-2 main protease (Mpro) with nanomolar affinity, but also viral replication. We present the first crystal structure of Mpro-Zn 2+ complex at 1.9 Å and provide the structural basis of viral replication inhibition. We show that Zn 2+ coordinates with the catalytic dyad at the enzyme active site along with two previously unknown water molecules in a tetrahedral geometry to form a stable inhibited Mpro-Zn 2+ complex. Further, natural ionophore quercetin increases the anti-viral potency of Zn 2+ . As the catalytic dyad is highly conserved across SARS-CoV, MERS-CoV and all variants of SARS-CoV-2, Zn 2+ mediated inhibition of Mpro may have wider implications.